CAROLYN CLARK: Open Payments
NPI 1679915664 · BRANSON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 52 payments from 16 companies in 2025. Trend: 2023 $1,269 · 2024 $1,118 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $359 |
| Novo Nordisk Inc | 7 | $129 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $105 |
| Abbott Laboratories | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| PFIZER INC. | 3 | $60 |
| Globus Medical, Inc. | 2 | $57 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $38 |
| Eisai Inc. | 2 | $38 |
Products named: FARXIGA, CAPLYTA, AIRSUPRA, BREZTRI, REXULTI, Ozempic, FREESTYLE LIBRE, Senza.
Industry payments across MO — which companies pay providers there.
